Why in news?
Recurrent miscarriages and unexplained blood clots in otherwise healthy individuals have drawn attention to Antiphospholipid Syndrome (APS). Physicians and patients are discussing this condition more often as awareness grows.
Background
APS is an autoimmune disorder in which the immune system produces antibodies that mistakenly attack proteins bound to phospholipids – key components of cell membranes. These antibodies make blood much more likely to clot. APS may occur on its own (primary) or alongside other autoimmune diseases, notably lupus (secondary). It affects more women than men and often manifests between 20 and 50 years of age.
Symptoms and risks
- Blood clots: deep vein thrombosis, pulmonary embolism and strokes are common manifestations. Small clots can also form in the kidneys and eyes, causing organ damage.
- Pregnancy complications: recurrent miscarriages, stillbirths, pre‑eclampsia and premature births are hallmark signs of APS. Proper diagnosis and management can improve outcomes.
- Skin and neurological signs: livedo reticularis (a lace‑like rash), migraines, seizures and memory problems may occur.
- Risk factors: having another autoimmune disease, infections, certain medications and prolonged immobility can trigger the syndrome. Smoking and high cholesterol further increase clotting risk.
Treatment and management
- Anticoagulants: there is no cure, but medicines such as low‑dose aspirin or warfarin reduce the risk of clot formation. During pregnancy, heparin injections may be used.
- Lifestyle changes: quitting smoking, maintaining a healthy weight and controlling blood pressure and cholesterol help lower risk.
- Regular monitoring: individuals with APS need regular blood tests to adjust medication doses and monitor for complications.
Conclusion
Antiphospholipid Syndrome is a serious but manageable condition. Early diagnosis and adherence to treatment can reduce the risk of blood clots and pregnancy loss, allowing affected individuals to lead normal lives.
Source: THE HINDU